Precision-distilled natural compounds manufactured under strict ISO and GMP specifications for international pharmaceutical, cosmetic, and oral care enterprise sourcing.
Modern pharmaceutical formulations and dental therapeutic manufacturing demand more than standard bulk essential oils. Formulating treatments for gum pain, periodontal inflammation, and pulpitis requires rectified, clinical-grade clove oil (Syzygium aromaticum) with standardized bioactive marker concentrations, guaranteed low moisture, and verified chemical integrity.
Dental therapeutic efficiency depends directly on pure Eugenol and Eugenyl Acetate fractions. Substandard crude oils fluctuate wildly (60-75%), causing unstable pain desensitization. Industrial procurement requires stabilized eugenol fractions ≥ 85% to maintain topical analgesic consistency under USP/EP compendial requirements.
When applied directly to oral mucosa, unrectified botanical impurities present acute toxicity hazards. Sourcing from certified manufacturers eliminates pesticide residues, aflatoxins, and heavy metals (Lead ≤ 3.0 ppm, Arsenic ≤ 1.0 ppm) through vacuum multi-stage fractional distillation without petroleum solvent interference.
Formulators encounter phase breakdown and oxidation when emulsifying clove oils into topical oral gels, varnishes, or surgical pastes. Bulk procurement necessitates batch-consistent refractive index (1.528–1.537) and optical rotation parameters, ensuring seamless carrier-oil integration without crystallization.
Evaluating commercial supply, origin geographic volatility, and upstream raw material dependencies ensures contract manufacturers mitigate stockouts and volatile price surges.
Geographic exposure centered in Indonesia, Madagascar, and Southern China exposes global buyers to monsoon shifts and harvesting disruptions. Strategic suppliers maintain multi-regional botanical reserves to insulate enterprise partners from global crop shortages.
Primary distillation often occurs at small-scale farm gates, leaving tar byproducts, scorched smells, and high water content. Industrial pharma suppliers operate enclosed stainless-steel steam fractionators to prevent compound degradation during initial extraction.
Refining raw crude clove oil into pharmaceutical grade requires molecular and vacuum rectification. This strips harsh non-active terpenes and caryophyllene over-concentrations, producing light, transparent oils optimized for gum soothing formulations.
Enterprise purchasers in North America and the European Union must navigate REACH registration, US FDA DMF filings, and ISO 22716 compliance. Reliable manufacturers maintain auditable supply traces from plant plantation through delivery.
| Analytical Specification | Commercial Grade (Crude) | Therapeutic Grade (Oral Care) | Baicao Pharma GMP Standard |
|---|---|---|---|
| Eugenol Content (GC-MS) | 60.0% – 75.0% | 80.0% – 85.0% | ≥ 85.0% (Customizable to 90%+) |
| Appearance & Color | Dark Amber / Brownish Liquid | Clear Yellow Liquid | Pale Yellow, High Clarity Liquid |
| Specific Gravity (20°C/20°C) | 1.025 – 1.050 | 1.038 – 1.060 | 1.042 – 1.054 |
| Refractive Index (20°C) | 1.520 – 1.540 | 1.528 – 1.537 | 1.530 – 1.535 |
| Phenol Red / Adulteration Test | Positive (Trace Synthetics) | Not Detected | 100% Pure Botanical Non-GMO |
Exploring how the molecular chemistry of Clove Oil (Syzygium aromaticum) targets pain pathways, interrupts bacterial biofilm accumulation, and leads dental medicine innovations.
Eugenol inhibits voltage-dependent sodium channels (VGSCs) within unmyelinated dental pulp C-fibers and periodontal A-delta fibers, suppressing pain neurotransmission directly from inflammed gingival tissues.
Acts as a direct anti-inflammatory agent by suppressing cyclooxygenase-2 (COX-2) expression and arachidonic acid conversion, reversing gingival swelling, redness, and microvascular edema in acute periodontitis.
Destabilizes cellular membranes of anaerobic oral pathogens including Porphyromonas gingivalis and Streptococcus mutans, preventing plaque-induced gum degradation and halitosis.
Next-generation development is moving toward submicron lipid carriers and thermo-reversible mucoadhesive matrices, providing 12-hour sustained release without oral wash-away effects.
Comprehensive laboratory testing and regulatory dossiers eliminate customs impounds and expedite global commercial market entry.
Every batch includes full Certificate of Analysis (COA) specifying gas chromatography peaks, 16-point GHS-compliant Material Safety Data Sheets (MSDS), TSE/BSE statements, Non-GMO declarations, and Allergen statements for international customs clearance.
Our modern inspection center in Jiangxi leverages high-performance liquid chromatography (HPLC), gas chromatography with flame ionization detection (GC-FID), and GC-MS equipment to screen against synthetic adulterants and solvent residues.
We support cross-border freight with UN-approved epoxy-lined steel drums (25kg, 50kg, 180kg), nitrogen headspace flushing to halt shelf oxidation, and DDP/CIF logistics dispatch to major port terminals across the Americas, Europe, and Asia-Pacific.
Crucial technical details required by formulation directors, regulatory affairs specialists, and procurement leads before placing contract manufacturing orders.
Explore complementary aromatic distillates, carrier bases, and botanical pain management actives produced at our 28,600 m² GMP facility.